A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis

NCT01458574 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

593

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Placebo
DRUG: CP690,550
DRUG: CP-690,550

Sponsor

Pfizer